124 related articles for article (PubMed ID: 37682602)
1. Topical 188Re Ionizing Radiation Therapy Exerts High Efficacy in Curing Nonmelanoma Skin Cancer.
Tietze JK; Heuschkel M; Krönert MIC; Kurth J; Bandow G; Ojak G; Grünwald P; Herold JI; Thiem A; Dreßler M; Krause BJ; Emmert S; Schwarzenböck SM
Clin Nucl Med; 2023 Oct; 48(10):869-876. PubMed ID: 37682602
[TBL] [Abstract][Full Text] [Related]
2. High dose brachytherapy with non sealed
Castellucci P; Savoia F; Farina A; Lima GM; Patrizi A; Baraldi C; Zagni F; Vichi S; Pettinato C; Morganti AG; Strigari L; Fanti S
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1511-1521. PubMed ID: 33140131
[TBL] [Abstract][Full Text] [Related]
3. Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study.
Cipriani C; Desantis M; Dahlhoff G; Brown SD; Wendler T; Olmeda M; Pietsch G; Eberlein B
J Dermatolog Treat; 2022 Mar; 33(2):969-975. PubMed ID: 32648530
[TBL] [Abstract][Full Text] [Related]
4. A novel tool for predicting the dose distribution of non-sealed
Zagni F; Vichi S; Paolani G; Santoro M; Della Gala G; Strolin S; Castellucci P; Vetrone L; Fanti S; Morganti AG; Strigari L
Med Phys; 2023 Jul; 50(7):4600-4612. PubMed ID: 36919341
[TBL] [Abstract][Full Text] [Related]
5. Systemic radionuclide therapy in pain palliation.
Liepe K; Runge R; Kotzerke J
Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
[TBL] [Abstract][Full Text] [Related]
6. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
[TBL] [Abstract][Full Text] [Related]
7. Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery.
Krönert MIC; Schwarzenböck SM; Kurth J; Heuschkel M; Krause BJ; Emmert S; Tietze JK
Healthcare (Basel); 2024 Apr; 12(9):. PubMed ID: 38727478
[TBL] [Abstract][Full Text] [Related]
8. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas.
Torres LA; Coca MA; Batista JF; Casaco A; Lopez G; García I; Perera A; Peña Y; Hernández A; Sanchez Y; Romero S; Leyva R; Prats A; Fernandez R
Nucl Med Commun; 2008 Jan; 29(1):66-75. PubMed ID: 18049099
[TBL] [Abstract][Full Text] [Related]
10. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study.
Perkins JL; Liu Y; Mitby PA; Neglia JP; Hammond S; Stovall M; Meadows AT; Hutchinson R; Dreyer ZE; Robison LL; Mertens AC
J Clin Oncol; 2005 Jun; 23(16):3733-41. PubMed ID: 15923570
[TBL] [Abstract][Full Text] [Related]
11. [Production and therapeutic use of rhenium-186, 188--the future of radionuclides].
Vucina J; Han R
Med Pregl; 2003; 56(7-8):362-5. PubMed ID: 14587255
[TBL] [Abstract][Full Text] [Related]
12. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
[TBL] [Abstract][Full Text] [Related]
14. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
[TBL] [Abstract][Full Text] [Related]
15. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds.
Knapp FF; Guhlke S; Beets AL; Lin WY; Stabin M; Amols H; Weinberger J
Cardiovasc Radiat Med; 1999; 1(1):86-97. PubMed ID: 11272362
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
[TBL] [Abstract][Full Text] [Related]
17. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy techniques in the treatment of skin cancer: an overview of the current status and outlook.
Pashazadeh A; Boese A; Friebe M
J Dermatolog Treat; 2019 Dec; 30(8):831-839. PubMed ID: 30703334
[TBL] [Abstract][Full Text] [Related]
19. Early effects of rhenium-188 treatment on proliferation, migration, and matrix synthesis of cultured human aortic smooth muscle cells.
Kehlbach R; Dittmann H; Schmid T; Khorchidi S; Bantleon R; Rodemann HP; Claussen CD; Duda SH; Wiskirchen J
Strahlenther Onkol; 2006 Mar; 182(3):164-71. PubMed ID: 16520911
[TBL] [Abstract][Full Text] [Related]
20. Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers.
Nowicki ML; Cwikla JB; Sankowski AJ; Shcherbinin S; Grimmes J; Celler A; Buscombe JR; Bator A; Pech M; Mikołajczak R; Pawlak D
Med Sci Monit; 2014 Aug; 20():1353-62. PubMed ID: 25086245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
